Novartis Pharma Schweiz AG
- A10 - Antidiabéticos
- GALVUMET film-coated tablet 1 000 mg+50 mg
- GALVUMET film-coated tablet 500 mg+50 mg
- GALVUMET film-coated tablet 850 mg+50 mg
- GALVUS tablet 50 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- ENTRESTO film-coated tablet 24 mg+26 mg
- ENTRESTO film-coated tablet 49 mg+51 mg
- ENTRESTO film-coated tablet 97 mg+103 mg
- EXFORGE film-coated tablet 160 mg+10 mg
- EXFORGE film-coated tablet 160 mg+5 mg
- EXFORGE film-coated tablet 80 mg+5 mg
- EXFORGE HCT film-coated tablet 160 mg+10 mg+12.5 mg
- EXFORGE HCT film-coated tablet 160 mg+10 mg+25 mg
- EXFORGE HCT film-coated tablet 160 mg+5 mg+12.5 mg
- EXFORGE HCT film-coated tablet 160 mg+5 mg+25 mg
- C10 - Agentes modificadores de los lípidos
- LESCOL prolonged-release capsule, hard 80 mg
- G02 - Otros preparados ginecológicos
- METHERGIN solution for injection 0.2 mg/1 ml
- H01 - Hormonas hipofisiarias, hipotalámicas y análogos
- SANDOSTATINE LAR powder and solvent for suspension for injection 10 mg
- SANDOSTATINE LAR powder and solvent for suspension for injection 20 mg
- SANDOSTATINE solution for injection 100 µg/1 ml
- SANDOSTATINE solution for injection 50 µg/1 ml
- L01 - Antineoplásicos
- AFINITOR tablet 10 mg
- AFINITOR tablet 5 mg
- JAKAVI tablet 15 mg
- JAKAVI tablet 20 mg
- JAKAVI tablet 5 mg
- KISQALI film-coated tablet 200 mg
- TASIGNA capsule, hard 150 mg
- TASIGNA capsule, hard 200 mg
- L02 - Terapia endocrina
- FEMARA film-coated tablet 2.5 mg
- L04 - Inmunosupresores
- CERTICAN tablet 0.5 mg
- GILENYA capsule, hard 0.5 mg
- SANDIMMUM concentrate for solution for infusion 250 mg/5 ml
- SANDIMMUN concentrate for solution for infusion 50 mg/1 ml
- SANDIMMUN NEORAL capsule, soft 100 mg
- SANDIMMUN NEORAL capsule, soft 25 mg
- SANDIMMUN NEORAL capsule, soft 50 mg
- SANDIMMUN NEORAL oral solution 100 mg/ml
- M03 - Relajantes musculares
- LIORESAL tablet 10 mg
- M05 - Preparados para el tratamiento de enfermedades óseas
- ACLASTA solution for infusion 5 mg/100 ml
- N03 - Antiepilépticos
- TEGRETOL oral suspension 2%
- TEGRETOL prolonged-release tablet 200 mg
- TEGRETOL prolonged-release tablet 400 mg
- N04 - Antiparkinsonianos
- COMTAN film-coated tablet 200 mg
- N05 - Psicolépticos
- LEPONEX tablet 100 mg
- LEPONEX tablet 25 mg
- N06 - Psicoanalépticos
- EXELON capsule, hard 1.5 mg
- EXELON capsule, hard 3 mg
- EXELON capsule, hard 4.5 mg
- EXELON capsule, hard 6 mg
- EXELON PATCH 10 transdermal patch 9.5 mg/24 h
- EXELON PATCH 5 transdermal patch 4.6 mg/24 h
- RITALIN tablet 10 mg
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- FORADIL inhalation powder, hard capsule 12 µg
- MIFLONIDE BREEZHALEER inhalation powder, hard capsule 200 µg
- MIFLONIDE BREEZHALER inhalation powder, hard capsule 400 µg
- ONBREZ BREEZHALER inhalation powder, hard capsule 150 µg
- XOLAIR powder and solvent for solution for injection 150 mg+2 ml
- S01 - Oftalmológicos
- LUCENTIS solution for injection 10 mg/ml
- MAXITROL eye drops, suspension
- TOBRADEX eye drops, suspension 0.1%+0.3%
- TOBRADEX eye drops, suspension 1 mg/g+3 mg/g
- TOBREX eye drops, solution 0.3%
- TOBREX eye ointment 0.3%
- V03 - Todos los demás preparados terapéuticos
- DESFERAL powder and solvent for solution for injection 500 mg+5 ml
- EXJADE dispersible tablet 125 mg
- EXJADE dispersible tablet 250 mg
- EXJADE dispersible tablet 500 mg